CD47 and glioblastoma: To determine the clinical relevance of EGFR and c‐Src activation‐regulated CD47 expression, we analyzed 25 human GBM specimens and showed that the levels of CD47 expression positively correlated with EGFR pY1068 and c‐Src pY416 (Figure 7A–C).